Previous 10 | Next 10 |
Chart Industries Set to Join S&P MidCap 400; Sonos & Embecta to Join S&P SmallCap 600 Chart Industries Set to Join S&P MidCap 400; Sonos & Embecta to Join S&P SmallCap 600 PR Newswire NEW YORK , March 25, 2022 /PRNewswire/ -- S...
BD Named One of America's Most Trusted Companies by Newsweek PR Newswire FRANKLIN LAKES, N.J. , March 25, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has be...
ICU Medical starts off 2022 with the considerable task of integrating Smiths Medical, a $2.35B deal that significantly expands ICUI's infusion business and adds complementary assets in other departments. In addition to leveraging even more scale, the Smiths deal gives ICU a more compe...
Cue Health (NASDAQ:HLTH -18.2%) has recorded its second-worst intraday decline for this month to hit a 52-week low as the health sector along with COVID-19 test makers underperform the broader market on Wednesday. Other notable decliners include Abbott Laboratories(ABT -4.0%), Bio-Rad La...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It has already been a turbulent year for investors, full of concerns ranging from geopolitical tensions and rampant inflation to interest rate hikes and the pandemic. The Russian invasion of Ukraine and rocketing crude oi...
Becton, Dickinson (NYSE:BDX) said its planned spinoff of Embecta will complete on April 1 when the stock will trade under the ticker "EMBC." The Record date for spin-off is March 22. After completion of the spinoff, every Becton, Dickinson (BDX) shareholder will receive one share of Embecta s...
BD Provides Update Regarding the Planned Spinoff of Embecta Corp. PR Newswire Record date for spin-off is March 22, 2022 "When Issued" trading of embecta common stock is expected to begin on March 21, 2022 , under the ticker "EMBCV" BD expects the spin-...
Raymond James has resumed coverage of Becton, Dickinson (BDX -0.7%) with a market perform rating to await a more attractive entry point. The firm did not set a target price. Analyst Jayson Bedford said that the stock's current valuation and year-to-date performance outperforming medtech peers...
We expect the interventional segment to continue maintaining its high growth as Becton, Dickinson focuses on transformational solutions. We believe the company may receive FDA clearance for its Alaris systems by April 2022, based on the average time for regulatory clearance in Europe ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...